SRH Wald-Klinikum Gera GmbH

Gera, Thuringia 07548

1 studies enrolling now · 5 studies all time

What they study most

BRAF or NRAS Mutant Metastatic Melanoma, Carcinoma, Non-Small-Cell Lung, Melanoma, Plaque Psoriasis

Studies at this site

• A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4) — Recruiting now
• A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis — Running, not enrolling
• A Trial to Learn if Fianlimab and Cemiplimab Are Safe and Work Better Than Anti-PD1 Alone in Adult Participants With Resectable Stage 3 or 4 Melanoma — Running, not enrolling
• A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period — Completed
• A Phase II Study of Single Agent MEK162 in Patients With Advanced Melanoma — Completed